| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc. | Director | Stock Option (right to buy) | 15.2K | 27 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | 27 Jun 2025 | 2 | $0 | 4 | Director | 01 Jul 2025, 13:57 |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | 27 Jun 2024 | 2 | $0 | 4 | Director | 15 Jul 2024, 11:09 |
| BSTG | Harvard Apparatus Regenerative Technology, Inc. | 26 Jul 2023 | 2 | $0 | 4 | Director | 28 Jul 2023, 16:00 |
| BSTG | Biostage, Inc. | 28 Feb 2023 | 3 | $0 | 4 | CEO as of 2/28/2023, Director | 02 Mar 2023, 19:00 |
| BSTG | Biostage, Inc. | 25 Jan 2023 | 1 | $0 | 4 | CEO, Director | 27 Jan 2023, 09:52 |
| BSTG | Biostage, Inc. | 12 May 2022 | 2 | $375K | 4 | Interim CEO, Director | 23 May 2022, 14:45 |
| BSTG | Biostage, Inc. | 26 Nov 2021 | 3 | $250K | 4 | Interim CEO, Director | 30 Nov 2021, 17:14 |
| BSTG | Biostage, Inc. | 26 Nov 2021 | 0 | $0 | 3 | Interim Chief Executive Officer, Director | 30 Nov 2021, 17:10 |